RSS Feed - Asia Pacific - Kaye Scholer LLP
Current Feed: http://www.kayescholer.com/practice/rss.xml?p=asia_pacific
Niping Wu (06/25/14)
Niping Wu is a partner in the firm’s Shanghai office. Niping’s practice focuses on cross-border mergers and acquisitions, in particular private equity downstream investment in the Asia-Pacific region and strategic investments in relation to Chinese target companies. She is distinguished as a leading private equity lawyer by Chambers Asia, and she is also recognized as a leading practitioner in Private Equity by Expert Guides. Niping regularly acts as counsel to international investors active in China, and she also has extensive experience in representing multinational companies in their direct investments into China.
Steven Glickstein (06/23/14)
Steven Glickstein has been a Kaye Scholer Partner since 1985. He is a member of the Product Liability Litigation and Counseling Group. During his 38 years of practice, Steve has been involved in some of the most highly publicized product liability litigation matters, including class actions that involve diverse products such as pharmaceuticals, medical devices, agricultural pesticides, blood products, asbestos, tobacco and other products. Steve served as Chair of the practice for 25 years during which time the team was recognized as the best product liability practice in the country by numerous publications, including Chambers and Partners (2008) and The American Lawyer (2006), as a result of its “unparalleled expertise in cutting edge product liability defense work.”
An Analysis on US Export Control Policy (06/16/14)
Diane Holt Frankle (06/12/14)
Diane Frankle represents publicly traded and privately held companies engaged in a wide variety of US and cross-border mergers, acquisitions, strategic alliances and joint ventures. Diane has completed more than 100 M&A deals with a total value exceeding $12 billion during the last 25 years. Her focus clients include companies in the technology, life sciences and health care industries, including those in software, internet security, storage, biotech, medical device, semiconductor, pharmaceutical and other sectors.
Benjamin C. Hsing (06/06/14)
Ben Hsing’s practice focuses on litigation and trials before the US district courts and the US International Trade Commission, and appeals to the US Court of Appeals for the Federal Circuit, concentrating on enforcement of US patent rights. Ben is an accomplished trial lawyer, and according to Chambers USA 2013, “senior in-house lawyers working for giants of the branded pharmaceuticals industry sing” his “praises,” stating that Ben’s “preparation was outstanding, and this really came across at the trial.” Chambers USA 2014, which recently recognized him as a leading patent litigator in New York, describes Ben as a “favorite of high-profile branded drug companies.”